Oppenheimer & Co. Inc. Has $11.21 Million Holdings in Xylem Inc. $XYL

Oppenheimer & Co. Inc. lessened its holdings in shares of Xylem Inc. (NYSE:XYL) by 23.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,010 shares of the industrial products company’s stock after selling 23,232 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Xylem were worth $11,211,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. SJS Investment Consulting Inc. lifted its position in Xylem by 1,844.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock worth $26,000 after buying an additional 166 shares in the last quarter. First Horizon Corp purchased a new stake in shares of Xylem during the third quarter worth $30,000. Grey Fox Wealth Advisors LLC acquired a new stake in Xylem during the third quarter valued at $34,000. Caldwell Trust Co purchased a new position in Xylem in the second quarter valued at about $41,000. Finally, FWL Investment Management LLC acquired a new position in Xylem in the 2nd quarter worth about $43,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

XYL has been the subject of several research reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Royal Bank Of Canada lifted their target price on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Citigroup increased their price target on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Zacks Research lowered shares of Xylem from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Finally, UBS Group increased their target price on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $165.80.

Xylem Price Performance

NYSE XYL opened at $140.35 on Tuesday. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a fifty day simple moving average of $139.48 and a 200 day simple moving average of $142.24. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. The company has a market cap of $34.17 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.02 and a beta of 1.17.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were paid a dividend of $0.40 per share. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem’s dividend payout ratio is presently 41.13%.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.